Frequent inactivating mutations of STAG2 in bladder cancer are associated with low tumour grade and stage and inversely related to chromosomal copy number changes

Human Molecular Genetics

Volumn 23, Issue 8, 2014, Pages 1964-1974

  Taylor, Claire F ^a   Platt, Fiona M ^a   Hurst, Carolyn D ^a   Thygesen, Helene H ^a   Knowles, Margaret A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN STAG2; UNCLASSIFIED DRUG;

ANEUPLOIDY; ARTICLE; CANCER CELL CULTURE; CANCER RECURRENCE; CANCER STAGING; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MISSENSE MUTATION; MUSCLE INVASIVE BLADDER CANCER; NONSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SEX DIFFERENCE; TRANSITIONAL CELL CARCINOMA;

ANTIGENS, NUCLEAR; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CHROMOSOMAL INSTABILITY; DNA COPY NUMBER VARIATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MUSCLE NEOPLASMS; MUTATION; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PHENOTYPE; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 84897865695     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt589     Document Type: Article

References (25)

1. Solomon, D.A., Kim, T., Diaz-Martinez, L.A., Fair, J., Elkahloun, A.G., Harris, B.T., Toretsky, J.A., Rosenberg, S.A., Shukla, N., Ladanyi, M. et al. (2011) Mutational inactivation of STAG2 causes aneuploidy in human cancer. Science, 333, 1039-1043.
2. Remeseiro, S. and Losada, A. (2013) Cohesin, a chromatin engagement ring. Curr. Opin. Cell Biol., 25, 63-71.
3. Remeseiro, S., Cuadrado, A., Carretero, M., Martinez, P., Drosopoulos, W.C., Canamero, M., Schildkraut, C.L., Blasco, M.A. and Losada, A. (2012) Cohesin-SA1 deficiency drives aneuploidy and tumourigenesis in mice due to impaired replication of telomeres. EMBO J., 31, 2076-2089.
4. Cuadrado, A., Remeseiro, S., Gomez-Lopez, G., Pisano, D.G. and Losada, A. (2012) The specific contributions of cohesin-SA1 to cohesion and gene expression: implications for cancer and development. Cell Cycle, 11, 2233-2238.
5. Xiao, T., Wallace, J. and Felsenfeld, G. (2011) Specific sites in the C terminus of CTCF interact with the SA2 subunit of the cohesin complex and are required for cohesin-dependent insulation activity. Mol. Cell. Biol., 31, 2174-2183.
6. Gui, Y., Guo, G., Huang, Y., Hu, X., Tang, A., Gao, S., Wu, R., Chen, C., Li, X., Zhou, L. et al. (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat. Genet., 43, 875-878.
7. Hurst, C.D., Platt, F.M., Taylor, C.F. and Knowles, M.A. (2012) Novel tumor subgroups of urothelial carcinoma of the bladder defined by integrated genomic analysis. Clin. Cancer Res., 18, 5865-5877.
8. Lindgren, D., Sjodahl, G., Lauss, M., Staaf, J., Chebil, G., Lovgren, K., Gudjonsson, S., Liedberg, F., Patschan, O., Mansson, W. et al. (2012) Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma. PloS one, 7, e38863.
9. Allory, Y., Beukers, W., Sagrera, A., Flandez, M., Marques, M., Marquez, M., van der Keur, K.A., Dyrskjot, L., Lurkin, I., Vermeij, M. et al. (2013) Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome. Eur. Urol. [Epub ahead of print].
10. Hurst, C.D., Platt, F.M. and Knowles, M.A. (2013) Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine. Eur. Urol. [Epub ahead of print].
11. Billerey, C., Chopin, D., Aubriot-Lorton, M.H., Ricol, D., Gil Diez de Medina, S., Van Rhijn, B., Bralet, M.P., Lefrere-Belda, M.A., Lahaye, J.B., Abbou, C.C. et al. (2001) Frequent FGFR3 mutations in papillary non-invasive bladder (pTa) tumors. Am. J. Pathol., 158, 1955-1959.
12. Platt, F.M., Hurst, C.D., Taylor, C.F., Gregory, W.M., Harnden, P. and Knowles, M.A. (2009) Spectrum of phosphatidylinositol 3-kinase pathway gene alterations in bladder cancer. Clin. Cancer Res., 15, 6008-6017.
13. Hauf, S., Roitinger, E., Koch, B., Dittrich, C.M., Mechtler, K. and Peters, J.M. (2005) Dissociation of cohesin from chromosome arms and loss of arm cohesion during early mitosis depends on phosphorylation of SA2. PLoS Biol, 3, e69.
14. Tarnowski, L.J., Kowalec, P., Milewski, M., Jurek, M., Plochocka, D., Fronk, J. and Kurlandzka, A. (2012) Nuclear import and export signals of human cohesinsSA1/STAG1 andSA2/STAG2 expressed in Saccharomyces cerevisiae. PloS one, 7, e38740.
15. Lara-Pezzi, E., Pezzi, N., Prieto, I., Barthelemy, I., Carreiro, C., Martinez, A., Maldonado-Rodriguez, A., Lopez-Cabrera, M. and Barbero, J.L. (2004) Evidence of a transcriptional co-activator function of cohesin STAG/SA/Scc3. J. Biol. Chem., 279, 6553-6559.
16. Taylor, C.F. (2009) Mutation scanning using high-resolution melting. Biochem. Soc. Trans., 37, 433-437.
17. Kim, M.S., Kim, S.S., Je, E.M., Yoo, N.J. and Lee, S.H. (2012) Mutational and expressional analyses of STAG2 gene in solid cancers. Neoplasma, 59, 524-529.
18. Fajkovic, H., Halpern, J.A., Cha, E.K., Bahadori, A., Chromecki, T.F., Karakiewicz, P.I., Breinl, E., Merseburger, A.S. and Shariat, S.F. (2011) Impact of gender on bladder cancer incidence, staging, and prognosis. World J. Urol., 29, 457-463.
19. Li, Y., Izumi, K. and Miyamoto, H. (2012) The role of the androgen receptor in the development and progression of bladder cancer. Jpn. J. Clin. Oncol., 42, 569-577.
20. Remeseiro, S., Cuadrado, A., Gomez-Lopez, G., Pisano, D.G. and Losada, A. (2012) Aunique role of cohesin-SA1 in gene regulation and development. EMBO J., 31, 2090-2102.
21. Rhodes, J.M., McEwan, M. and Horsfield, J.A. (2011) Gene regulation by cohesin in cancer: is the ring an unexpected party to proliferation? Mol. Can. Res., 9, 1587-1607.
22. Dorsett, D. (2011) Cohesin: genomic insights into controlling gene transcription and development. Curr. Opin. Genet. Dev., 21, 199-206.
23. UICC. (1978) TNM Classification of Malignant Tumors, Bladder. Union Internationale Contre le Cancer, Geneva, pp. 113-117.
24. WHO. (1973) Histological Typing of Urinary Bladder Tumours. World Health Organisation, Geneva.
25. Chapman, E.J., Hurst, C.D., Pitt, E., Chambers, P., Aveyard, J.S. and Knowles, M.A. (2006) Expression of hTERT immortalises normal human urothelial cells without inactivation of the p16/Rb pathway. Oncogene, 25, 5037-5045.